(BZH) Beazer Homes USA - Overview
Stock: Single-Family, Condominiums, Villas, Duets, Homebuilder
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 49.9% |
| Relative Tail Risk | -10.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.37 |
| Alpha | -1.27 |
| Character TTM | |
|---|---|
| Beta | 0.996 |
| Beta Downside | 0.780 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.79% |
| CAGR/Max DD | 0.38 |
Description: BZH Beazer Homes USA December 25, 2025
Beazer Homes USA, Inc. (NYSE:BZH) is a U.S. homebuilder founded in 1985 and based in Atlanta, Georgia. It designs, constructs, and sells a range of residential properties-including single-family homes, condominiums, villas, and “duet” homes-under the Beazer Homes, Gatherings, and Choice Plans brands, utilizing both in-house sales counselors and independent realtors.
Key operational metrics as of FY 2023 show approximately 7,200 homes delivered, an average selling price (ASP) of $380 k (up ~5 % YoY), and a backlog of roughly 5,000 units, indicating solid pipeline strength. The homebuilding sector remains highly sensitive to mortgage-rate movements and housing-starts data; the latest Fed policy outlook suggests rates could hover near 5 % through 2024, which historically depresses demand but also narrows competition among builders with strong balance sheets.
If you want a data-rich, scenario-based view of Beazer’s valuation and risk profile, the ValueRay platform provides the granular analytics needed for deeper research.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 9.86m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA 3.48 > 1.0 |
| NWC/Revenue: 98.59% < 20% (prev 88.70%; Δ 9.89% < -1%) |
| CFO/TA 0.01 > 3% & CFO 26.0m > Net Income 9.86m |
| Net Debt (-120.8m) to EBITDA (34.6m): -3.49 < 3 |
| Current Ratio: 19.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.9m) vs 12m ago -6.08% < -2% |
| Gross Margin: 13.83% > 18% (prev 0.17%; Δ 1366 % > 0.5%) |
| Asset Turnover: 86.49% > 50% (prev 92.76%; Δ -6.28% > 0%) |
| Interest Coverage Ratio: 1.75 > 6 (EBITDA TTM 34.6m / Interest Expense TTM 8.86m) |
Altman Z'' 6.36
| A: 0.85 (Total Current Assets 2.35b - Total Current Liabilities 120.1m) / Total Assets 2.64b |
| B: 0.15 (Retained Earnings 391.2m / Total Assets 2.64b) |
| C: 0.01 (EBIT TTM 15.5m / Avg Total Assets 2.62b) |
| D: 0.27 (Book Value of Equity 391.2m / Total Liabilities 1.44b) |
| Altman-Z'' Score: 6.36 = AAA |
Beneish M -2.57
| DSRI: 1.40 (Receivables 92.8m/70.7m, Revenue 2.27b/2.41b) |
| GMI: 1.25 (GM 13.83% / 17.31%) |
| AQI: 0.92 (AQ_t 0.07 / AQ_t-1 0.07) |
| SGI: 0.94 (Revenue 2.27b / 2.41b) |
| TATA: -0.01 (NI 9.86m - CFO 26.0m) / TA 2.64b) |
| Beneish M-Score: -2.57 (Cap -4..+1) = A |
What is the price of BZH shares?
Over the past week, the price has changed by +16.13%, over one month by +21.19%, over three months by +13.61% and over the past year by +11.04%.
Is BZH a buy, sell or hold?
- StrongBuy: 4
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BZH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26 | 3.8% |
| Analysts Target Price | 26 | 3.8% |
| ValueRay Target Price | 27.2 | 8.4% |
BZH Fundamental Data Overview February 01, 2026
P/E Forward = 68.4932
P/S = 0.2684
P/B = 0.5303
P/EG = 3.4238
Revenue TTM = 2.27b USD
EBIT TTM = 15.5m USD
EBITDA TTM = 34.6m USD
Long Term Debt = 1.13b USD (from longTermDebt, last quarter)
Short Term Debt = 8.74m USD (from shortTermDebt, two quarters ago)
Debt = 1.06b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -120.8m USD (from netDebt column, last quarter)
Enterprise Value = 1.57b USD (636.5m + Debt 1.06b - CCE 120.8m)
Interest Coverage Ratio = 1.75 (Ebit TTM 15.5m / Interest Expense TTM 8.86m)
EV/FCF = -563.5x (Enterprise Value 1.57b / FCF TTM -2.79m)
FCF Yield = -0.18% (FCF TTM -2.79m / Enterprise Value 1.57b)
FCF Margin = -0.12% (FCF TTM -2.79m / Revenue TTM 2.27b)
Net Margin = 0.44% (Net Income TTM 9.86m / Revenue TTM 2.27b)
Gross Margin = 13.83% ((Revenue TTM 2.27b - Cost of Revenue TTM 1.95b) / Revenue TTM)
Gross Margin QoQ = 10.24% (prev 13.49%)
Tobins Q-Ratio = 0.60 (Enterprise Value 1.57b / Total Assets 2.64b)
Interest Expense / Debt = 1.06% (Interest Expense 11.2m / Debt 1.06b)
Taxrate = 21.0% (US default 21%)
NOPAT = 12.2m (EBIT 15.5m * (1 - 21.00%))
Current Ratio = 19.59 (Total Current Assets 2.35b / Total Current Liabilities 120.1m)
Debt / Equity = 0.88 (Debt 1.06b / totalStockholderEquity, last quarter 1.20b)
Debt / EBITDA = -3.49 (Net Debt -120.8m / EBITDA 34.6m)
Debt / FCF = 43.27 (negative FCF - burning cash) (Net Debt -120.8m / FCF TTM -2.79m)
Total Stockholder Equity = 1.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.38% (Net Income 9.86m / Total Assets 2.64b)
RoE = 0.81% (Net Income TTM 9.86m / Total Stockholder Equity 1.22b)
RoCE = 0.66% (EBIT 15.5m / Capital Employed (Equity 1.22b + L.T.Debt 1.13b))
RoIC = 0.53% (NOPAT 12.2m / Invested Capital 2.32b)
WACC = 4.13% (E(636.5m)/V(1.69b) * Re(9.59%) + D(1.06b)/V(1.69b) * Rd(1.06%) * (1-Tc(0.21)))
Discount Rate = 9.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -1.63%
Fair Price DCF = unknown (Cash Flow -2.79m)
EPS Correlation: -68.60 | EPS CAGR: -56.95% | SUE: -4.0 | # QB: 0
Revenue Correlation: -4.76 | Revenue CAGR: -8.56% | SUE: -1.23 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.61 | Chg30d=+0.410 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-09-30): EPS=1.48 | Chg30d=+0.045 | Revisions Net=-1 | Growth EPS=-22.2% | Growth Revenue=+5.6%
EPS next Year (2027-09-30): EPS=2.42 | Chg30d=-0.540 | Revisions Net=-1 | Growth EPS=+63.5% | Growth Revenue=+12.1%